Scientific Opinion on the substantiation of health claims related to riboflavin (vitamin B2) and contribution to normal energy-yielding metabolism (ID 29, 35, 36, 42), contribution to normal metabolism of iron (ID 30, 37), maintenance of normal skin and m

Products, Efsa Panel on Dietetic

doi:10.2903/j.efsa.2010.1814

Cited by 16 publications

(10 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The EFSA Panel on Food Additives and Nutrient Sources added to food (ANS) issued a statement on the inability to assess the safety of riboflavin-enriched yeast added for nutritional purposes as a source of riboflavin in food supplements and the bioavailability of riboflavin from this source, based on the supporting dossier (EFSA, 2009). The EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) issued several opinions on the substantiation of several health claims related to riboflavin (EFSA NDA Panel, 2010, 2013a. The ANS Panel issued an opinion on the re-evaluation of riboflavin (E 101(i)) and riboflavin-5 0 -phosphate (E 101(ii)) as part of the food additives re-evaluation programme specified under Regulation ( Riboflavin sodium phosphate is included in the current issue (9th edition) of the European Pharmacopeia (PhEur), Monograph (MG) 0786 (European Pharmacopeia (PhEur), 2016).…”

Section: Additional Informationmentioning

confidence: 99%

Safety and efficacy of vitamin B2 (riboflavin 5′‐phosphate ester monosodium salt) for all animal species when used in water for drinking

Additives¹,

Bampidis²,

Azimonti³

et al. 2018

EFS2

View full text Add to dashboard Cite

Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on vitamin B 2 in the form of riboflavin 5 0 -phosphate ester monosodium salt as an additive for all animal species for use in water for drinking. The additive under assessment is obtained from a source of riboflavin produced by Ashbya gossypii. No information was provided on the identity and characterisation of the production strain, and on whether or not it is a genetically modified microorganism. Therefore, in the absence of adequate information, it is not possible to perform an assessment of the safety of the production strain. Riboflavin 5 0 -phosphate ester monosodium salt 'per se' is considered safe for the target animals, consumers and the environment. In the absence of data regarding the identity and characterisation of the production strain, the FEEDAP Panel cannot conclude on the safety for the target species, consumers, users and the environment of the riboflavin 5 0 -phosphate ester monosodium salt under assessment. Similarly, in the absence of data, no conclusion can be reached on the safety of the product for the users. Riboflavin 5 0 -phosphate ester monosodium salt is regarded as effective in covering the animal's requirement when administered via water for drinking. and Tarres-Call J, 2018. Safety and efficacy of vitamin B 2 (riboflavin 5 0 -phosphate ester monosodium salt) for all animal species when used in water for drinking. EFSA Journal 2018;16(12):5531, 15 pp. https://doi.org/10.

show abstract

Section: Additional Informationmentioning

confidence: 99%

Safety and efficacy of vitamin B2 (riboflavin 5′‐phosphate ester monosodium salt) for all animal species when used in water for drinking

Additives¹,

Bampidis²,

Azimonti³

et al. 2018

EFS2

View full text Add to dashboard Cite

show abstract

“…The present opinion does not constitute, and cannot be construed as, an authorisation for the marketing of riboflavin, a positive assessment of its safety, nor a decision on whether riboflavin is, or is not, classified as a foodstuff. It should be noted that such an assessment is not foreseen in the framework of Regulation (EC) No 1924 It should also be highlighted that the scope, the proposed wording of the claim, and the conditions of use as proposed by the applicant may be subject to changes, pending the outcome of the authorisation procedure foreseen in Article 17 of Regulation (EC) No 1924/2006.…”

Section: Efsa Disclaimermentioning

confidence: 99%

“…EFSA is requested to evaluate the scientific data submitted by the applicant in accordance with Article 16 of Regulation (EC) No 1924. On the basis of that evaluation, EFSA will issue an opinion on the scientific substantiation of a health claim related to: riboflavin and contribution to normal energy-yielding metabolism.…”

Section: Terms Of Referencementioning

confidence: 99%

“…The Panel has already assessed a claim on riboflavin and contribution to normal energy-yielding metabolism with a favourable outcome (EFSA NDA Panel, 2010). The target population was the general population.…”

Section: Scientific Substantiation Of the Claimed Effectmentioning

confidence: 99%

“…

ABSTRACTFollowing an application from Specialised Nutrition Europe (formerly IDACE), submitted pursuant to Article 14 of Regulation (EC) No 1924 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to riboflavin (vitamin B2) and contribution to normal energy-yielding metabolism. The food constituent, riboflavin, which is the subject of the health claim, is sufficiently characterised.

…”

mentioning

confidence: 99%

See 2 more Smart Citations

Scientific Opinion on the substantiation of a health claim related to riboflavin (vitamin B2) and contribution to normal energy‐yielding metabolism pursuant to Article 14 of Regulation (EC) No 1924/2006

Products¹

2013

EFS2

View full text Add to dashboard Cite

Following an application from Specialised Nutrition Europe (formerly IDACE), submitted pursuant to Article 14 of Regulation (EC) No 1924 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to riboflavin (vitamin B2) and contribution to normal energy-yielding metabolism. The food constituent, riboflavin, which is the subject of the health claim, is sufficiently characterised. Contribution to normal energyyielding metabolism is a beneficial physiological effect for infants and young children. A claim on riboflavin and contribution to normal energy-yielding metabolism in the general population has already been assessed with a favourable outcome. The Panel notes that the role of riboflavin on normal energy-yielding metabolism applies to all ages, including infants and young children (from birth to three years). The Panel concludes that a cause and effect relationship has been established between the dietary intake of riboflavin and contribution to normal energy-yielding metabolism. was asked to deliver an opinion on the scientific substantiation of a health claim related to riboflavin (vitamin B2) and contribution to normal energy-yielding metabolism. © EuropeanThe scope of the application was proposed to fall under a health claim referring to children's development and health.The food constituent that is the subject of the health claim is riboflavin (vitamin B2), which is an essential nutrient and is measurable in foods by established methods. The Panel considers that riboflavin is sufficiently characterised.The claimed effect proposed by the applicant is "has an important role as a coenzyme in energyyielding metabolism". The target population proposed by the applicant is infants and young children from birth to three years of age. The Panel considers that contribution to normal energy-yielding metabolism is a beneficial physiological effect for infants and young children.A claim on riboflavin and contribution to normal energy-yielding metabolism in the general population has already been assessed with a favourable outcome. The conclusion of the Panel was based on the well-established role of riboflavin in energy-yielding metabolism as shown by the evidence provided by consensus opinions/reports from authoritative bodies and reviews.The Panel notes that the role of riboflavin on normal energy-yielding metabolism applies to all ages, including infants and young children (from birth to three years).The Panel concludes that a cause and effect relationship has been established between the dietary intake of riboflavin and contribution to normal energy-yielding metabolism.The following wording reflects the scientific evidence: "Riboflavin contributes to normal energyyielding metabolism".The Panel considers that in order to bear the claim, follow-on formulae should comply with the criteria of composition of follow-on formulae as laid down in Directive 2006/141/EC; nutriti...

show abstract

The Role of B Group Vitamins and Choline in Cognition and Brain Aging

Bonetti

Brombo

Zuliani

2017

Nutrition and Functional Foods for Healthy Aging

View full text Add to dashboard Cite

Scientific Opinion on the substantiation of health claims related to riboflavin (vitamin B2) and contribution to normal energy-yielding metabolism (ID 29, 35, 36, 42), contribution to normal metabolism of iron (ID 30, 37), maintenance of normal skin and m

Cited by 16 publications

References 17 publications

Safety and efficacy of vitamin B2 (riboflavin 5′‐phosphate ester monosodium salt) for all animal species when used in water for drinking

Safety and efficacy of vitamin B2 (riboflavin 5′‐phosphate ester monosodium salt) for all animal species when used in water for drinking

Scientific Opinion on the substantiation of a health claim related to riboflavin (vitamin B2) and contribution to normal energy‐yielding metabolism pursuant to Article 14 of Regulation (EC) No 1924/2006

The Role of B Group Vitamins and Choline in Cognition and Brain Aging

Contact Info

Product

Resources

About